Recovery of lymphocyte and dendritic cell subsets after autologous CD34+ cell transplantation

被引:0
|
作者
A Galy
S Rudraraju
R Baynes
J Klein
机构
[1] Stem Cell Transplantation Program,
[2] Barbara Ann Karmanos Cancer Institute,undefined
[3] Wayne State University,undefined
来源
关键词
dendritic cells; naive T cells; CD34; cell transplant; flow cytometry;
D O I
暂无
中图分类号
学科分类号
摘要
Following high-dose chemotherapy (HDC) and peripheral blood progenitor cell transplantation (PBPCT), there are profound changes in leukocyte homeostasis and the immune system is compromised. Transplantation of purified CD34+ cells may further compromise immune recovery because the grafts are depleted of mature immune cells. However, a detailed monitoring of immune cell reconstitution has not been done. We monitored blood levels of antigen-presenting cells (APC) and of lymphocytes by multi-color flow cytometry at different times post CD34+ PBPCT. We found a rapid normalization of circulating levels of the antigen-presenting CD11c+ dendritic cells (defined as lineage− HLA-DR+ CD11c+ cells). There was a slight over-representation of lin− DR+ CD11c− cells at day 42 post transplantation suggesting that the composition of the APC population might be affected. Normal levels of total T, B and NK lymphocytes were rapidly achieved but the composition of the T cell population was abnormal. Patients had elevated levels of CD8+ T cells at early times and a persistent reduction in levels of naive CD8+ T cells (CD8+ CD4− CD45RA+ CD27+) and of naive CD4+ T cells (CD4+CD3+ CD8− CD45RA+). Thus, we found a rapid recovery of DC after CD34+ PBPCT but the specific numerical defects in naive T cells are likely to be a major cause of immune dysfunction in the patients. Bone Marrow Transplantation (2000) 25, 1249–1255.
引用
收藏
页码:1249 / 1255
页数:6
相关论文
共 50 条
  • [1] Recovery of lymphocyte and dendritic cell subsets after autologous CD34+ cell transplantation
    Galy, A
    Rudraraju, S
    Baynes, R
    Klein, J
    BONE MARROW TRANSPLANTATION, 2000, 25 (12) : 1249 - 1255
  • [2] Recovery of lymphocyte and dendritic cell subsets after autologous stem cell transplantation
    Galy, A
    Rudraraju, S
    Klein, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (01) : 235 - 235
  • [3] Evaluation of CD 34 cell subsets composition in leukapheresis products and their impact on the haematopoletic recovery after autologous transplantation
    Dmoszynska, A.
    Gromek, T.
    Cioch, M.
    Wach, M.
    Walter-Croneck, A.
    Jawniak, A.
    Manko, J.
    Legiec, W.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S156 - S156
  • [4] In vitro migratory capacity of CD34+ cells is related to hematopoietic recovery after autologous stem cell transplantation
    Voermans, C
    Kooi, MLK
    Rodenhuis, S
    van der Lelie, H
    van der Schoot, GE
    Gerritsen, WR
    BLOOD, 2001, 97 (03) : 799 - 804
  • [5] Dendritic cell recovery after autologous stem cell transplantation
    D Damiani
    R Stocchi
    P Masolini
    A Michelutti
    A Sperotto
    A Geromin
    C Skert
    M Cerno
    M Michieli
    M Baccarani
    R Fanin
    Bone Marrow Transplantation, 2002, 30 : 261 - 266
  • [6] Dendritic cells - Dendritic cell recovery after autologous stem cell transplantation
    Damiani, D
    Stocchi, R
    Masolini, P
    Michelutti, A
    Sperotto, A
    Geromin, A
    Skert, C
    Cerno, M
    Michieli, M
    Baccarani, M
    Fanin, R
    BONE MARROW TRANSPLANTATION, 2002, 30 (05) : 261 - 266
  • [7] High CD34+ cell dose promotes faster platelet recovery after autologous stem cell transplantation for acute myeloid leukemia
    Gunn, N
    Damon, L
    Varosy, P
    Navarro, W
    Martin, T
    Ries, C
    Linker, C
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (10) : 643 - 648
  • [8] Cell adhesion molecule expression on CD34+ cells in grafts and time to myeloid and platelet recovery after autologous stem cell transplantation
    Watanabe, T
    Dave, B
    Heimann, DG
    Jackson, JD
    Kessinger, A
    Talmadge, JE
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (01) : 10 - 18
  • [9] Autologous CD34+ selected peripheral stem cell transplantation (ASCT/CD34+) for multiple sclerosis (MS).
    Carreras, E
    Saiz, A
    Graus, F
    Marín, P
    Urbano-Ispizua, A
    Mercader, JM
    Martínez, C
    Rovira, M
    Mazzara, R
    Merino, A
    Tolosa, E
    Montserrat, E
    BONE MARROW TRANSPLANTATION, 1999, 23 : S33 - S33
  • [10] Early lymphocyte recovery is delayed after CD34+selected autologous peripheral blood stem cell transplantation
    Scheid, C
    Nockenberg, K
    Hinrichs, R
    Fuchs, M
    Winter, S
    Schulz, A
    Diehl, V
    Söhngen, D
    BONE MARROW TRANSPLANTATION, 2001, 27 : S124 - S125